Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Thomas Malley


  • Director at Ovascience Inc. (OVAS), 2016-10-04
  • Director at Kura Oncology Inc. (KURA), 2016-05-13
  • Director at Beigene Ltd. (BGNE), 2016-02-03
  • Director at Synageva Biopharma Corp (GEVA), 2015-06-23
  • Director at Puma Biotechnology Inc. (PBYI), 2014-12-17
  • Director at Cougar Biotechnology Inc. (CGRB), 2009-07-07
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaning Holdings Date Form 4
KURA $8.00 50,000 Director 89,557 2015-11-10 Filing
OVAS $28.50 5,000 Director 122,200 2015-04-08 Filing
OVAS $50.00 35,000 Director 116,819 2015-01-13 Filing
OVSC $9.00 50,000 Director 81,819 2013-03-18 Filing
PBYI $16.00 10,000 Director 156,551 2012-10-24 Filing

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!